2005, Number 5
<< Back Next >>
Rev Invest Clin 2005; 57 (5)
Anthropometricalmeasurements as predictor of serum lipid profile in adolescents with Down syndrome
Ordóñez-Munoz FJ, Rosety-Rodríguez M, Rosety-Rodríguez JM, Rosety-Plaza M
Language: Spanish
References: 22
Page: 691-694
PDF size: 50.70 Kb.
ABSTRACT
Current findings suggest that more attention needs to be given to the increase in body mass being achieved by disabled populations in general and individuals with mental retardation in particular, to minimize long-term negative health consequences. Given that physical activity programs have been reported as one of the most effective ways of improving the health of individuals with Down syndrome, it would be of interest facilitate different tools to contribute to their clinical follow-up. Consequently, this study was designed to assess the correlation between anthropometrical parameters and lipid profile in adolescents with Down syndrome. Anthropometric variables such as body mass index, waist circumference and waist-to-hip ratio as well as serum lipids (total cholesterol, high-density-lipoprotein cholesterol, total-cholesterol/high-density-lipoprotein cholesterol and triglycerides) were measured in 21 male adolescents (16.3 ± 1.1 years) with Down syndrome. Anthropometric parameters presented a positive association with serum lipids except for high-density-lipoprotein cholesterol that was negative. It should be emphasized the strongest association of waist-to-hip ratio to total cholesterol/high-density-lipoprotein cholesterol ratio (r = 0.48; p ‹ 0.05). It is concluded waist circumference and waist-to-hip ratio may be highly recommended in clinical practice as appropriate anthropometric predictors of lipid profile in adolescents with Down syndrome. Further studies are required to assess their behavior during physical activity programs as well as to determine more correlations in these individuals.
REFERENCES
James PT. Obesity: the worldwide epidemic. Clin Dermatol 2004; 22: 276-80.
Lerman-Garber I, Villa AR, Caballero E. Diabetes and cardiovascular disease. Is there a true Hispanic paradox? Rev Invest Clin 2004; 56: 282-96.
Melville CA, Cooper SA, McGrother C, Thorp CF, Collacott R. Obesity in adults with Down syndrome: a case-control study. J Intellect Disabil Res 2005; 49: 125-33.
Jobling A. Life be in it: lifestyle choices for active leisure. Down Syndr Res Pract 2001; 6: 117-22.
Luke A, Sutton M, Schoeller DA, Roizen NJ. Nutrient intake and obesity in prepubescent children with Down syndrome. J Am Diet Assoc 1996; 96: 1262-7.
Pueschel SM. Should children with Down syndrome be screened for atlantoaxial instability? Arch Pediatr Adolesc Med 1998; 152: 123-5.
Hill DA, Gridley G, Cnattingius S, Mellemkjaer L, Linet M, Adami HO, et al. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 2003; 163: 705-11.
Ordoñez FJ, Rosety-Rodriguez M, Rosety M. Influence of 12-week exercise training on fat mass in adolescents with Down syndrome. Med Sci Monit 2005 (Aceptado).
Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tato L. Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res 2001; 9: 179-87.
Viroonudomphol D, Pongpaew P, Tungtrongchitr R, Changbumrung S, Tungtrongchitr A, Phonrat B, et al. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects. Asia Pac J Clin Nutr 2003; 12: 73-9.
Ganiats TG, Cantor SB. Cost-effectiveness and Down syndrome. Am J Public Health 1999; 89: 110-12.
Tsimaras V, Giagazoglou P, Fotiadou E, Christoulas K, Angelopoulou N. Jog-walk training in cardiorespiratory fitness of adults with Down syndrome. Percept Mot Skills 2003; 96: 1239-51.
Vogels A, Fryns JP. Age at diagnosis, body mass index, and physical morbidity in children and adults with Prader-Willi syndrome. Genet Couns 2004; 15: 397-404.
Fan Y, Rahman P, Peddle L, Hefferton D, Gladney N, Moore SJ, et al. Bardet-Biedl syndrome 1 genotype and obesity in the Newfoundland population. Int J Obes Relat Metab Disord 2004; 28: 680-4.
Rubin SS, Rimmer JH, Chicoine B, Braddock D, McGuire DE. Overweight prevalence in persons with Down syndrome. Ment Retard 1998; 36: 175-81.
Megnien JL, Denarie N, Cocaul M, Simon A, Levenson J. Predictive value of waist-to-hip ratio on cardiovascular risk events. Int J Obes Relat Metab Disord 1999; 23: 90-7.
Sonmez K, Akcakoyun M, Akcay A, Demir D, Duran NE, Gencbay M, et al. Which method should be used to determine the obesity, in patients with coronary artery disease? (body mass index, waist circumference or waist-hip ratio). Int J Obes Relat Metab Disord 2003; 27: 341-6.
Donnelly LF, O’Brien KJ, Dardzinski BJ, Poe SA, Bean JA, Holland SK, et al. Using a phantom to compare MR techniques for determining the ratio of intraabdominal to subcutaneous adipose tissue. Am J Roentgenol 2003; 180: 993-8.
Chan YL, Leung SS, Lam WW, Peng XH, Metreweli C. Body fat estimation in children by magnetic resonance imaging, bioelectrical impedance, skinfold and body mass index: a pilot study. J Paediatr Child Health 1998; 34: 22-8.
Braunschweig CL, Gomez S, Sheean P, Tomey KM, Rimmer J, Heller T. Nutritional status and risk factors for chronic disease in urban-dwelling adults with Down syndrome. Am J Ment Retard 2004; 109: 186-93.
Castelli WP. Cholesterol and lipids in the risk of coronary artery disease- the Framingham Heart Study. Can J Cardiol 1988; 4: 5-10.
Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987–1993. Am J Epidemiol 1997; 146: 483-94.